MSBIS: A Multi-Step Biomedical Informatics Screening Approach for Identifying Medications that Mitigate the Risks of Metoclopramide-Induced Tardive Dyskinesia

In 2009 the U.S. Food and Drug Administration (FDA) placed a black box warning on metoclopramide (MCP) due to the increased risks and prevalence of tardive dyskinesia (TD). In this study, we developed a multi-step biomedical informatics screening (MSBIS) approach leveraging publicly available bioact...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Dong, Ham, Alexandrea G., Tivis, Rickey D., Caylor, Matthew L., Tao, Aoxiang, Flynn, Steve T., Economen, Peter J., Dang, Hung K., Johnson, Royal W., Culbertson, Vaughn L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5832625/
https://www.ncbi.nlm.nih.gov/pubmed/29191560
http://dx.doi.org/10.1016/j.ebiom.2017.11.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5832625/
https://www.ncbi.nlm.nih.gov/pubmed/29191560
http://dx.doi.org/10.1016/j.ebiom.2017.11.015

Ejemplares similares